Mean | SEM | 95% CI | Post hoc (Bonferroni) | ||||
---|---|---|---|---|---|---|---|
cases | Lower | Upper | |||||
age ANOVA F: 9.08, P < 0.0001 | MO | 176 M; 471 F | 37.49 | 0.52 | 36.46 | 38.51 | Vs CM p < 0.001 |
MA | 3 M; 9 F | 28.55 | 3.91 | 20.86 | 36.23 | Vs CM p 0.005 | |
MO + MA | 17 M; 39 F | 35.91 | 1.89 | 32.20 | 39.63 | Vs CM p 0.009 | |
CM | 78 M; 218 F | 40.94 | 0.79 | 39.40 | 42.49 | ||
migraine duration ANOVA F: 1.44, P 0.22 | MO | 15.53 | 0.47 | 14.62 | 16.45 | n.s. | |
MA | 11.27 | 3.49 | 4.42 | 18.12 | |||
MO + MA | 16.74 | 1.69 | 13.43 | 20.06 | |||
CM | 16.70 | 0.70 | 15.32 | 18.08 | |||
headache frequency ANOVA F: 238.39, P < 0.0001 | MO | 9.61 | 0.27 | 9.08 | 10.13 | Vs CM p < 0.001 | |
MA | 6.82 | 2.00 | 2.90 | 10.74 | Vs CM p < 0.001 | ||
MO + MA | 9.24 | 0.97 | 7.35 | 11.14 | Vs CM p < 0.001 | ||
CM | 22.26 | 0.40 | 21.47 | 23.05 | |||
MIDAS ANOVA F: 27.93, p < 0.0001 | MO | 25.62 | 1.70 | 22.29 | 28.95 | Vs CM p < 0.001 | |
MA | 18.82 | 12.68 | −6.06 | 43.70 | Vs CM p 0.048 | ||
MO + MA | 20.77 | 6.13 | 8.73 | 32.80 | Vs CM p < 0.001 | ||
CM | 52.99 | 2.55 | 47.99 | 58.00 | |||
headache intensity (0–100 VAS) ANOVA F: 4.67, p 0.005 | MO | 8.74 | 0.05 | 8.65 | 8.83 | Vs CM p 0.007 | |
MA | 8.82 | 0.34 | 8.14 | 9.49 | |||
MO + MA | 9.09 | 0.17 | 8.76 | 9.41 | |||
CM | 9.04 | 0.07 | 8.90 | 9.17 | |||
Allodynia F: 0.80, p 0.01 | MO | 2.67 | 0.08 | 2.51 | 2.82 | n.s. | |
MA | 1.82 | 0.60 | 0.64 | 3.00 | |||
MO + MA | 3.15 | 0.29 | 2.58 | 3.72 | |||
CM | 3.01 | 0.12 | 2.78 | 3.25 | |||
SAS F: 8.57, p < 0.001 | MO | 36.68 | 0.37 | 35.97 | 37.40 | Vs CM p < 0.001. | |
MA | 35.64 | 2.75 | 30.24 | 41.04 | |||
MO + MA | 36.04 | 1.28 | 33.53 | 38.55 | Vs CM p 0.035 | ||
CM | 39.88 | 0.55 | 38.81 | 40.95 | |||
SDS F: 11.2, p < 0.001 | MO | 35.28 | 0.38 | 34.52 | 36.03 | Vs CM p < 0.001. | |
MA | 30.36 | 2.90 | 24.68 | 36.05 | Vs CM: p 0.023 | ||
MO + MA | 34.82 | 1.35 | 32.18 | 37.47 | Vs CM p 0.03 | ||
CM | 38.94 | 0.57 | 37.82 | 40.07 |